Back
Perspective Therapeutics Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
30
CATX
Perspective Therapeutics
Last Price:
13.38
Seasonality Move:
-10.19%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.97 | Sell |
| 20-day SMA: | 15.14 | Sell |
| 50-day SMA: | 13.64 | Sell |
| 200-day SMA: | 11.16 | Buy |
| 8-day EMA: | 14.56 | Sell |
| 20-day EMA: | 14.66 | Sell |
| 50-day EMA: | 14 | Sell |
| 200-day EMA: | 11.47 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 41.66 | Sell |
| Chaikin Money Flow: | 400659 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 15.77) | Sell |
| Bollinger Bands (100): | (11.56 - 16.02) | Sell |
Perspective Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.32 while CATX 8-day simple moving average is 14.97, which is a Sell signal.
- The stock price of CATX is 13.32 while Perspective Therapeutics 20-day SMA is 15.14, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 13.64 while CATX share price is 13.32, making it a Sell technically.
- CATX stock price is 13.32 and Perspective Therapeutics 200-day simple moving average is 11.16, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $13.32. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
898.14M
Price in USD:
13.32
Share Volume:
664.99K
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.20
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 13.32 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.32 while CATX 8-day exponential moving average is 14.56, which is a Sell signal.
- The stock price of CATX is 13.32 while Perspective Therapeutics 20-day EMA is 14.66, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 14.00 while CATX share price is 13.32, making it a Sell technically.
- CATX stock price is 13.32 and Perspective Therapeutics 200-day simple moving average is 11.47, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Perspective Therapeutics is a Buy
- Perspective Therapeutics Relative Strength Index (RSI) is 41.66, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (13.87 - 15.77), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (11.56 - 16.02), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.